Emory Alzheimer's Disease Research Center

埃默里阿尔茨海默病研究中心

• 批准号: 10408030
• 负责人: DAVID WEINSHENKER
• 金额: $ 15.69万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-15 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10408030
• 关键词: Achievement; Address; Advisory Committees; Affect; Alzheimer' s Disease; Alzheimer' s disease related dementia; Alzheimer' s disease therapeutic; American; Area; Behavioral; Biomedical Engineering; Catalogs; Clinical; Clinical Research; Clinical Sciences; Companions; Complement; Data Science; Dementia; Diagnostic; Discipline; Education; Educational Activities; Educational Curriculum; Educational workshop; Environment; Evaluation; Faculty; Fostering; Funding; Future; Generations; Goals; Institution; Laboratories; Lead; Leadership; Mentors; Mentorship; Methodology; Minority; Mission; Molecular; Monitor; Neurosciences; Output; Participant; Pathogenicity; Postdoctoral Fellow; Prevalence; Prevention; Recording of previous events; Research; Research Activity; Research Personnel; Research Support; Research Training; Resources; Scientist; Standardization; System; Teacher Professional Development; Time; Training; Training Programs; Translational Research; Translations; Underrepresented Minority; Universities; Work; career; cohort; education research; education resources; experience; innovation; instrument; meetings; minority investigator; minority trainee; multidisciplinary; next generation; programs; recruit; skills; success; symposium; targeted biomarker; therapeutic target; tool; translational scientist

SUMMARY/ABSTRACT: RESEARCH EDUCATION COMPONENT Alzheimer’s disease (AD) is the most common cause of dementia, affecting more than 5 million Americans. At the same time that the prevalence of AD is increasing, the number of new investigators in the US is decreasing, which may severely hamper our efforts to develop better diagnostic and treatment tools for AD and related dementias (ADRD). The goal of the Research Education Component (REC) of the Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory is to support research educational activities that complement and enhance the training of the future workforce to meet the nation’s biomedical, behavioral and clinical needs in ADRD. We will achieve this goal by identifying and supporting the research education of junior investigators and trainees from diverse backgrounds and disciplines. In Aim 1, REC leadership and mentors will work with these trainees to develop and execute tailored educational plans for new and early stage investigators to advance towards independence in conducting AD-related research. In Aim 2, we will leverage Emory’s wealth of basic and clinical scientists as well as partner Atlanta-area institutions to identify, recruit and support the research training of new/early stage investigators and trainees from diverse backgrounds and disciplines, with special emphasis on URMs, to engage in AD-related research. In Aim 3, the REC leadership and external advisory committee will rigorously monitor and evaluate the trainees, mentors, and the overall program, and implement improvements when necessary. Success of the REC will result in rolling cohorts of new investigators with a focus on diversity to lead the next generation of ADRD research.

摘要/摘要：研究教育部分 阿尔茨海默氏病（AD）是痴呆症最常见的原因，影响了超过500万美国人。 同时，AD的患病率正在增加，美国的新调查人员数量是 减少，这可能会严重阻碍我们为AD开发更好的诊断和治疗工具的努力， 相关痴呆症（ADRD）。 Goizueta研究教育部分（REC）的目标 Emory的阿尔茨海默氏病研究中心（ADRC）是为了支持研究教育活动 补充和增强对未来劳动力的培训，以满足国家的生物医学，行为和 ADRD的临床需求。我们将通过识别和支持初级的研究教育来实现这一目标 来自潜水员背景和学科的研究人员和学员。在AIM 1中，REC领导和导师 将与这些受训者合作，制定和执行量身定制的教育计划 研究人员在进行广告相关研究方面迈向独立性。在AIM 2中，我们将利用 埃默里（Emory 支持来自潜水员背景的新/早期调查员和学员的研究培训 学科特别强调URMS，参与与广告有关的研究。在AIM 3中，REC领导 外部咨询委员会将严格监视和评估培训，导师和整体 编程，并在必要时实施改进。 REC的成功将导致滚动队列 专注于多样性的新研究人员领导下一代ADRD研究。